Mihai Gheorghiade Selected Research

Digoxin (Digitek)

6/2015	Digoxin use in atrial fibrillation: a critical reappraisal.
5/2014	The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions.
8/2013	Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
8/2013	Drug therapy to reduce early readmission risk in heart failure: ready for prime time?
5/2013	Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?
5/2013	Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
5/2013	Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
12/2012	Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
1/2012	Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF.
11/2009	Reconsidering the role for digoxin in the management of acute heart failure syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mihai Gheorghiade Research Topics

Disease

330	Heart Failure 11/2021 - 01/2002
27	Myocardial Infarction 01/2020 - 10/2002
22	Left Ventricular Dysfunction 10/2019 - 03/2002
21	Hyponatremia 06/2013 - 06/2003
20	Atrial Fibrillation 10/2018 - 01/2002
15	Body Weight (Weight, Body) 02/2016 - 06/2003
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2003
12	Hypotension (Low Blood Pressure) 01/2016 - 03/2002
11	Systolic Heart Failure 10/2016 - 01/2002
10	Dyspnea (Shortness of Breath) 01/2018 - 03/2007
10	Cardiomyopathies (Cardiomyopathy) 01/2017 - 03/2003
9	Diabetes Mellitus 01/2018 - 04/2004
8	Hypertension (High Blood Pressure) 05/2016 - 04/2008
8	Edema (Dropsy) 07/2012 - 06/2003
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 08/2005
6	Inflammation (Inflammations) 01/2017 - 02/2008
6	Chronic Renal Insufficiency 07/2016 - 06/2012
6	Acute Coronary Syndrome 02/2016 - 10/2002
5	Ischemia 04/2017 - 09/2002
5	Disease Progression 06/2013 - 06/2006
5	Cardio-Renal Syndrome 03/2013 - 09/2005
4	Stroke (Strokes) 01/2020 - 11/2013
4	Fibrosis (Cirrhosis) 06/2017 - 11/2006
4	Ventricular Remodeling 01/2017 - 04/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2016 - 07/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 02/2013
3	Cardiac Arrhythmias (Arrythmia) 10/2016 - 07/2011
3	Hyperkalemia 10/2016 - 03/2013
3	Neoplasms (Cancer) 02/2016 - 01/2016
3	Hypokalemia 03/2015 - 04/2004
3	Anemia 05/2014 - 09/2003
3	Low Cardiac Output 09/2013 - 12/2006
3	Systemic Scleroderma (Systemic Sclerosis) 03/2013 - 08/2011
3	Renal Insufficiency (Renal Failure) 03/2013 - 05/2006
3	Insulin Resistance 02/2013 - 04/2003
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2011 - 04/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2009 - 09/2002

Drug/Important Bio-Agent (IBA)

53	Tolvaptan FDA Link 01/2018 - 02/2003
48	Vasopressins (Vasopressin)IBA 01/2018 - 06/2003
30	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 01/2002
23	SodiumIBA 11/2021 - 06/2003
21	Pharmaceutical PreparationsIBA 01/2019 - 10/2002
20	Angiotensin Receptor AntagonistsIBA 01/2018 - 05/2006
20	Mineralocorticoid Receptor AntagonistsIBA 07/2016 - 08/2008
19	Antidiuretic Hormone Receptor AntagonistsIBA 01/2015 - 07/2003
18	Digoxin (Digitek)FDA LinkGeneric 06/2015 - 01/2002
15	DiureticsIBA 01/2017 - 01/2002
13	Natriuretic PeptidesIBA 01/2020 - 10/2011
12	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2015 - 02/2003
11	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2002
10	Milrinone (Primacor)FDA LinkGeneric 05/2008 - 03/2002
8	Soluble Guanylyl CyclaseIBA 01/2017 - 12/2009
8	Eplerenone (Inspra)FDA LinkGeneric 07/2016 - 08/2005
8	CreatinineIBA 04/2016 - 12/2006
8	AldosteroneIBA 11/2013 - 08/2005
8	Arginine Vasopressin (Argipressin)IBA 01/2013 - 07/2003
8	Carvedilol (Coreg)FDA LinkGeneric 01/2007 - 01/2002
7	Adenosine (Adenocard)FDA LinkGeneric 11/2018 - 08/2010
7	ElectrolytesIBA 09/2014 - 04/2004
7	IstaroximeIBA 08/2011 - 01/2007
7	Dobutamine FDA LinkGeneric 05/2008 - 02/2003
6	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2018 - 03/2007
6	aliskiren FDA Link 01/2018 - 01/2011
6	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 06/2009
6	Neurotransmitter Agents (Neurotransmitter)IBA 09/2012 - 09/2005
5	RivaroxabanIBA 01/2020 - 02/2011
5	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2018 - 05/2006
5	PotassiumIBA 10/2016 - 06/2007
5	Urea (Carbamide)FDA LinkGeneric 01/2016 - 12/2006
5	NitrogenIBA 01/2016 - 12/2006
5	Amino Acids FDA Link 01/2015 - 04/2003
4	CollagenIBA 01/2017 - 02/2008
4	vericiguatIBA 01/2017 - 09/2014
4	finerenoneIBA 07/2016 - 06/2012
4	Vasodilator Agents (Vasodilators)IBA 07/2015 - 09/2005
4	Hemoglobins (Hemoglobin)IBA 12/2014 - 01/2008
4	CytokinesIBA 02/2009 - 04/2003
4	tezosentanIBA 06/2004 - 10/2002
3	TroponinIBA 01/2018 - 09/2010
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2014 - 02/2008
3	AnticoagulantsIBA 11/2013 - 04/2011
3	Warfarin (Coumadin)FDA LinkGeneric 11/2013 - 05/2003
3	Hydralazine (Apresoline)FDA LinkGeneric 06/2013 - 05/2003
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2013 - 01/2012
3	BAY 58-2667IBA 01/2013 - 12/2009
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2011 - 02/2009
3	Hormones (Hormone)IBA 06/2008 - 04/2003
2	CalciumIBA 02/2019 - 10/2013
2	neladenoson bialanateIBA 11/2018 - 01/2017
2	Thrombin FDA Link 10/2018 - 07/2015
2	ReninIBA 01/2018 - 11/2017
2	Renin InhibitorsIBA 01/2018 - 10/2013

Therapy/Procedure

158	Therapeutics 01/2018 - 01/2002
25	Patient Readmission 01/2020 - 09/2003
16	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 08/2014 - 05/2003
15	Cardiac Resynchronization Therapy 08/2014 - 03/2004
9	Length of Stay 10/2015 - 05/2004
5	Liver Transplantation 12/2016 - 07/2006
4	Contraindications 05/2013 - 01/2003
3	Transplantation 03/2013 - 01/2008